Drug Product
Company Overview
About
Rivopharm SA is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Quality Control, Stability Testing, Method Development
Therapeutic Areas
Cardiovascular
Endocrinology
Quick Facts
HQ:Switzerland
Founded:2005
Employees:1,973
Capabilities & Services
Core Capabilities
- Sterile Injectable
- Sterile Fill/Finish
- Fill/Finish (Vials)
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Cartridge / Pen
Containment Capabilities
BSL-2 (Biosafety Level 2)
Production Scales
Pilot Scale
Clinical
Commercial Scale
Markets Served
Europe
Manufacturing Facilities
1 site worldwide
RIVOPHARM SA
CENTRO INSEMA, MANNO, TI, 6928
Site Capabilities
4 capabilitiesANALYSIS
LABEL
MANUFACTURE
PACK
International Regulatory
EU GMP Certificates
3
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval 63Q43X
Health Canada · #APR-FNQ6QK3S · 2021-09-01
Drug Approval 00MOWX
PMDA · #APR-7LQ3R85O · 2022-01-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-BSMVGPID
Issued: 2020-06-23
Expires: 2025-05-24
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-P3PBMLB1
Issued: 2020-01-02
Expires: 2025-05-08
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-JZ2ATA4S
Issued: 2020-07-27
Expires: 2025-09-12
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-4R5S144V
Issued: 2020-02-25
Expires: 2025-06-21
Loading CDMO intelligence...
Key facts about Rivopharm SA
- Rivopharm SA is headquartered in Switzerland.
- Rivopharm SA was founded in 2005.
- Rivopharm SA has 1,973 employees.
- Rivopharm SA has one manufacturing site listed on CDMO Hub, in MANNO, Switzerland.
- Rivopharm SA's capabilities include Sterile Injectable, Sterile Fill/Finish and Fill/Finish (Vials).
Find CDMOs like Rivopharm SA
Directory pages this company appears in, each with the full list of matching manufacturers.